- Home
- DCTH vs ABSI Comparison
DCTH vs ABSI Comparison
Compare DCTH & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DCTH
- ABSI
- Stock Information
- Founded
- DCTH 1988
- ABSI 2011
- Country
- DCTH United States
- ABSI United States
- Employees
- DCTH N/A
- ABSI N/A
- Industry
- DCTH Medical/Dental Instruments
- ABSI Biotechnology: Pharmaceutical Preparations
- Sector
- DCTH Health Care
- ABSI Health Care
- Exchange
- DCTH Nasdaq
- ABSI Nasdaq
- Market Cap
- DCTH 394.9M
- ABSI 338.0M
- IPO Year
- DCTH N/A
- ABSI 2021
- Fundamental
- Price
- DCTH $10.89
- ABSI $2.54
- Analyst Decision
- DCTH Strong Buy
- ABSI Strong Buy
- Analyst Count
- DCTH 4
- ABSI 5
- Target Price
- DCTH $24.50
- ABSI $7.98
- AVG Volume (30 Days)
- DCTH 825.0K
- ABSI 5.2M
- Earning Date
- DCTH 08-06-2025
- ABSI 08-12-2025
- Dividend Yield
- DCTH N/A
- ABSI N/A
- EPS Growth
- DCTH N/A
- ABSI N/A
- EPS
- DCTH 0.06
- ABSI N/A
- Revenue
- DCTH $70,240,000.00
- ABSI $4,138,000.00
- Revenue This Year
- DCTH $160.46
- ABSI $74.53
- Revenue Next Year
- DCTH $42.87
- ABSI $296.01
- P/E Ratio
- DCTH $195.18
- ABSI N/A
- Revenue Growth
- DCTH 491.35
- ABSI 27.32
- 52 Week Low
- DCTH $8.08
- ABSI $2.01
- 52 Week High
- DCTH $18.23
- ABSI $6.33
- Technical
- Relative Strength Index (RSI)
- DCTH 48.16
- ABSI 38.07
- Support Level
- DCTH $10.06
- ABSI $2.49
- Resistance Level
- DCTH $10.81
- ABSI $2.73
- Average True Range (ATR)
- DCTH 0.71
- ABSI 0.19
- MACD
- DCTH 0.13
- ABSI -0.05
- Stochastic Oscillator
- DCTH 28.57
- ABSI 5.49
About DCTH Delcath Systems Inc.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.